Females | Males | |||
---|---|---|---|---|
BSI rate ratio (95% CI) | p-value | BSI rate ratio (95% CI) | p-value | |
BSI, allover | 1.028 (1.010–1.047) | 0.003 | 1.011(0.993–1.029) | 0.22 |
Place of acquisition | ||||
Community acquired | 0.998 (0.973–1.024) | 0.88 | 0.976 (0.950–1.004) | 0.09 |
Health care-associated | 1.080 (1.047–1.114) | <0.001 | 1.053 (1.024–1.083) | <0.001 |
Hospital acquired | 1.009 (0.954–1.067) | 0.76 | 0.999 (0.956–1.043) | 0.96 |
Infection focus | ||||
Urinary tract | 1.056 (1.027–1.086) | <0.001 | 1.041 (1.008–1.075) | 0.013 |
Lungs | 1.021 (0.974–1.071) | 0.39 | 0.969 (0.930–1.010) | 0.14 |
Biliary tract | 1.017 (0.959–1.079) | 0.57 | 0.993 (0.944–1.045) | 0.80 |
Gastrointestinal tract | 1.017 (0.933–1.108) | 0.70 | 1.052 (0.975–1.136) | 0.19 |
Skin or soft tissue | 0.934 (0.868–1.005) | 0.069 | 0.979 (0.920–1.042) | 0.51 |
Other | 0.989 (0.935–1.045) | 0.69 | 1.040 (0.991–1.091) | 0.11 |
Unknown | 1.043 (0.981–1.109) | 0.17 | 0.987 (0.935–1.041) | 0.64 |
Microbe group | ||||
Gram-negative BSI | 1.043 (1.019–1.068) | <0.001 | 1.020 (0.995–1.046) | 0.12 |
Gram-positive BSI | 0.997 (0.966–1.030) | 0.87 | 0.993 (0.968–1.020) | 0.62 |
Polymicrobial or fungal BSI | 1.031 (0.936–1.135) | 0.54 | 1.095 (1.007–1.190) | 0.034 |
Microbes (the four most common) | ||||
Escherichia coli | 1.044 (1.015–1.073) | 0.003 | 1.002 (0.967–1.037) | 0.92 |
Streptococcus pneumoniae | 1.007 (0.954–1.063) | 0.80 | 0.908 (0.860–0.958) | <0.001 |
Staphylococcus aureus | 0.988 (0.926–1.055) | 0.73 | 1.032 (0.984–1.082) | 0.20 |
Klebsiella spp. | 1.136 (1.053–1.224) | 0.001 | 1.094 (1.020–1.175) | 0.012 |